CINECA IRIS Institutional Research Information System

DI STILO, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.577
EU - Europa 3.033
AS - Asia 2.246
SA - Sud America 193
AF - Africa 59
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.139
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.471
CN - Cina 988
SG - Singapore 699
IE - Irlanda 413
SE - Svezia 404
DE - Germania 381
IT - Italia 373
UA - Ucraina 292
FR - Francia 269
FI - Finlandia 243
GB - Regno Unito 190
KR - Corea 184
BR - Brasile 168
PL - Polonia 141
VN - Vietnam 114
AT - Austria 104
CA - Canada 89
IN - India 76
BE - Belgio 41
JP - Giappone 37
NL - Olanda 37
RU - Federazione Russa 35
HK - Hong Kong 33
ID - Indonesia 33
SN - Senegal 28
AU - Australia 24
RO - Romania 18
GR - Grecia 16
TR - Turchia 16
CH - Svizzera 12
HU - Ungheria 12
TW - Taiwan 12
ES - Italia 11
CZ - Repubblica Ceca 9
CL - Cile 8
IL - Israele 8
IQ - Iraq 8
BD - Bangladesh 7
DK - Danimarca 7
MX - Messico 7
DZ - Algeria 6
IS - Islanda 6
PT - Portogallo 6
UZ - Uzbekistan 6
VE - Venezuela 6
IR - Iran 5
TH - Thailandia 5
HR - Croazia 4
KE - Kenya 4
MU - Mauritius 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SC - Seychelles 4
ZA - Sudafrica 4
AM - Armenia 3
CO - Colombia 3
CR - Costa Rica 3
EC - Ecuador 3
EU - Europa 3
MA - Marocco 3
PK - Pakistan 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
EG - Egitto 2
MY - Malesia 2
PA - Panama 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AR - Argentina 1
BG - Bulgaria 1
BJ - Benin 1
BY - Bielorussia 1
CY - Cipro 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
LT - Lituania 1
LV - Lettonia 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PR - Porto Rico 1
TN - Tunisia 1
Totale 10.139
Salva come PNG Salva come JPEG
Città #
Chandler 610
Beijing 452
Dublin 410
Ann Arbor 359
Singapore 305
Santa Clara 243
Fairfield 239
Ashburn 203
Jacksonville 181
Dearborn 136
Warsaw 135
Houston 131
Villeurbanne 130
Woodbridge 128
Medford 119
Princeton 118
Wilmington 118
Nyköping 116
Munich 111
Vienna 101
Seattle 98
Pisa 92
Columbus 83
Dong Ket 81
Cambridge 77
Torino 61
Shanghai 58
Redwood City 53
Milan 48
Fremont 47
Guangzhou 46
Boardman 41
Boston 40
Brussels 39
Nanjing 33
Rome 33
Helsinki 31
Jakarta 28
New York 28
Ottawa 28
Toronto 27
Hangzhou 23
Hong Kong 23
Nuremberg 23
Düsseldorf 21
Jinan 20
Falls Church 19
Norwalk 19
Amsterdam 17
Verona 17
Hefei 15
Lachine 15
Philadelphia 15
Shenyang 15
Turku 15
San Jose 14
São Paulo 14
Washington 14
Pune 13
Phoenix 12
San Diego 12
Zhengzhou 12
Melbourne 11
Hanoi 10
Harbin 10
Belo Horizonte 9
Chengdu 9
Mumbai 9
Wuhan 9
Xian 9
Chongqing 8
Kunming 8
Nanchang 8
Pittsburgh 8
Seoul 8
Silver Spring 8
The Dalles 8
Tokyo 8
Chicago 7
Los Angeles 7
Madrid 7
Monmouth Junction 7
Falkenstein 6
Fuzhou 6
Kharkiv 6
Athens 5
Budapest 5
Cangzhou 5
Changsha 5
Copenhagen 5
Council Bluffs 5
Curitiba 5
Dallas 5
Frankfurt am Main 5
Hamilton 5
Moscow 5
Mountain View 5
Paris 5
Qingdao 5
Rivoli 5
Totale 6.026
Salva come PNG Salva come JPEG
Nome #
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis 687
Stable Oxidative Cytosine Modifications Accumulate in Cardiac Mesenchymal Cells from Type2 Diabetes Patients: Rescue by alpha Ketoglutarate and TET-TDG Functional Reactivation 518
1,1-Dinitroethyl substituted furoxans : a new class of vasodilators and inhibitors of platelet aggregation 369
Validation of a GC/MS method for the detection of two quinoline-derived selective androgen receptor modulators in doping control analysis 230
(Nitrooxyacyloxy)methyl esters of aspirin as novel nitric oxide releasing aspirins 218
New nitric oxide or hydrogen sulfide releasing aspirins 190
Development of a new class of potential antiatherosclerosis agents: NO-donor antioxidants 180
Effects of Nitric Oxide Donor Antioxidants Containing the Phenol Vitamin E Substructure and a Furoxan Moiety on Ischemia/Riperfusion Injury 179
Nitrooxymethyl Substituted Analogues of Celecoxib: Synthesis and Pharmacological Characterization 159
A new class of NO-donor H3-Antagonists 157
Nitrooxymethyl-Substituted Analogues of Rofecoxib: Synthesis and Pharmacological Characterization 155
A LIPOPHILIC NITRIC OXIDE-DONOR AND A LIPOPHILIC ANTIOXIDANT COMPOUND PROTECT RAT HEART AGAINST ISCHEMIA-REPERFUSION INJURY IF GIVEN AS HYBRID MOLECULE BUT NOT AS A MIXTURE. 154
Microwave-assisted synthesis of N-heterocycles in medicinal chemistry 154
Multitarget Drugs: Synthesis and Preliminary Pharmacological Characterization of Zileuton Analogues Endowed with Dual 5-LO Inhibitor and NO-Dependent Activities 152
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs) 144
Amphiphilic NO-Donor Antioxidants 144
Design, Synthesis and Pharmacological Evaluation of Anti-Pyroptotic Compounds Acting on NLRP3 Inflammasome Signaling Pathway: a New Start for Anti-Inflammatory Drugs? 140
Use of Nitric Oxide Releasing Furoxan System in the Design of "Hybrids": Substitution of Furoxan Moieties for the Furan Ring in Prazosin 138
Multitarget Drugs: Focus on the NO-donor hybrid drugs 133
Cardiac Epi-Metabolic Signature Revealed by Integrated Omics Approach in Diabetic Patients: Rescue by Active DNA Demethylation via TET-TDG Complex Reactivation 130
NO-donors: focus on furoxan derivatives 130
Synthesis of Some Novel Organic Nitrates and Comparative in Vitro Study of Their Vasodilator Profile 125
Applicazione di una tecnica innovativa alle analisi per i controlli antidoping: determinazione di diuretici mediante fast-GC/MS 123
New organic nitrate-containing benzyloxy isonipecotanilide derivatives with vasodilatory and anti-platelet activity 122
Non-conventional extractions and antioxidant properties evaluation of microalga Spirulina maxima 121
Fast gaschromatographic/mass spectrometric determination of diuretics and masking agents in human urine. Development and validation of a productive screening protocol for antidoping analysis 117
SAR STUDIES ON H2 ANTAGONISTS CONTAINING ALKYLAMINO SUBSTITUTED 1,2,5-THIADIAZOLE 1-OXIDE MOIETIES 116
ALPHA(1)-ADRENOCEPTOR BLOCKING ACTIVITY OF SOME RING-OPEN ANALOGS OF PRAZOSIN 115
New potential uroselective NO-donor a1-antagonists 113
Anti-Helicobacter pylori Agents Endowed with H2-antagonist Properties 113
[3-(1H-Imidazol-4-yl)propyl)guanidines Containing Furoxan Moieties: A New Class of H3-Antagonists Endowed with NO-Donor Properties 112
Use of the Morita-Baylis-Hillman reaction in the design of compounds inhibiting NLRP3 inflammasome signaling pathways 112
NO-Donor Phenols: A New Class of Products Endowed with Antioxidant and Vasodilator Properties 111
Synthesis and Structure of a Trimer of the Furoxan System with High Vasodilator and Platelet Antiaggregatory Activity 111
Targeting NLRP3 inflammasome regulatory mechanisms: design of anti-pyroptotic compounds for autoinflammatory diseases 109
Characterisation of Furoxancarbonitriles as a New Class of Vasodilators 108
Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives 106
Recent advances in the cyclization of N-heterocycles: the role of enabling techniques 104
Synthesis and preliminary evaluation of model compounds targeting the NLRP3 inflammasome pathways 104
Furoxan derivatives as NO-donors 101
Pharmacochemistry of the Furoxan Ring : Recent Developments 100
CC1000: a new cardioprotective agent against ischemia/reperfusion injuries 99
Searching for Balanced Hybrid NO-Donor 1,4-Dihydropyridines with Basic Properties 97
"Enabling Technologies": a Step ahead in the Synthesis of Nitrogen-Containing Heterocycles 97
Novel Organic Nitrate Esters 96
WATER SOLUBLE FUROXAN DERIVATIVES AS NO PRODRUGS 95
New 1,4-Dihydropyridines Conjugated to Furoxanyl Moieties, endowed With both NO-like and Ca2+ Channel Antagonist Vasodilator Activities 93
Studies on New Basic NO-Donor 1,4-Dihydropyridines 91
Synthesis and structural characterization of the trimeric furoxan (equals furazan 2-oxide) system, a new potent vasodilating moiety 90
Identification of Small Synthetic Anti-Pyroptotic Compounds 87
Combined protective effect of nitric oxide donor and antioxidants in the rat heart 85
Cytotoxic Activity of a Series of Heteroaryl-ONN-azoxysulphones and Arylsulphonylhydrazones 85
Synthesis and H2-Antagonist Properties of some 1,2,5-Thiadiazole-1-oxide Derivatives 84
Cyano-NNO-azoxy Analogs of Nifedipine 84
Mass spectrometry of quinolinone-derived selective androgen receptor modulators (SARMs) 84
Furoxans as Nitric Oxide Donors. 4-Phenyl-3-furoxancarbonitrile: Thiol-Mediated Nitric Oxide Release and Biological Evaluation 83
Effetto del post-condizionamento farmacologico sui danni da ischemia e riperfusione 82
Furan and Thiophene analogues of omeprazole 77
Unsymmetrically Substituted Furoxans. Part 11. Methylfuroxancarbaldehydes 75
Synthesis and Pharmacological Evaluation of Novel H3 Antagonists Endowed with NO-Donor Properties 74
L'effetto protettivo di un ibrido con proprietà antiossidante e NO donatrice contro i danni da ischemia e riperfusione nel cuore isolato di ratto 73
In Vitro Cytotoxic Activity of Aryl and Heteroaryl-ONN-Azoxycyanides 73
Low concentrations of an nitric oxide-donor combined with a liposoluble antioxidant compound enhance protection against reperfusion injury in isolated rat hearts 72
Use of Nitric Oxide Releasing Furoxan System in the Design of Hybrids With mixed NO-like Vasodilator Activity and *1-Antagonistic Properties 70
Nitric oxide and antioxidant activity in the protection of the heart ischemia/reperfusion injury 69
The Cyano-NNO-Azoxy Function in the Design of an Irreversible Label for a1 Adrenoreceptors 69
NO donor - melatonins: a new class of potential antiatherosclerosis agents 67
Studies on Agents with Mixed NO-Dependent and Calcium Channel Antagonistic Vasodilating Activities. 65
Myocardial protection in the rat heart and role of weak and strong NO-release from a hybrid molecule containing an antioxidant substructure 63
NO donor and biological properties of different benzofuroxans. 61
Synthesis, chiral HPLC resolution and configuration assignment of 1-phenylglyceryl trinitrate stereomers 60
The Furoxan System as a Useful Tool to Balancing "Hybrids" with mixed alfa1-Antagonist and NO-Like Vasodilator Activities 60
Vasodilating profile of a new series of analogues of GTN 59
New NO-donor Bisphosphonates 59
Synthesis and vasodilating properties of N-alkylamide derivatives of 4-amino-3-furoxancarboxylic acid and related azo derivatives 58
Non-imidazole histamine NO-donor H3-antagonists 58
Pyrazole analogues of prazosin 58
Nitric oxide release by an edavarone derivative containing NOdonor furoxan moiety contributes to the resolution of renal injury after ischemia/reperfusion in the rat 58
Validation of a GC/MS method for the detection of two quinolinone-derived selective androgen receptor modulators in doping control analysis 57
STUDIES ON AGENTS WITH MIXED NO-DEPENDENT VASODILATING AND β-BLOCKING ACTIVITIES 57
New 1,4-dihydropyridines endowed with NO-donor and calcium channel agonist properties 55
Post-conditioning with NO-donors and antioxidant compounds 54
New Uroselective NO-Donor a1-antagonists 53
Tolerance profile of new organic nitrates with antioxidant properties 53
Studies of the potential genotoxic effects of furoxans: the case of CAS 1609 and of the water soluble analogue of CHF 2363 53
Physicochemical profile and in vitro permeation behavior of a new class of non-steroidal anti-inflammatory drug candidates 51
High-speed gas chromatography in doping control: Fast-GC and fast-GC/MS determination of beta-adrenoceptor ligands and diuretics 50
In vitro and in vivo vasodilating activity of nitroso derivatives gem -substituted with electron-withdrawing groups. 49
Michael addition of Grignard reagents to tetraethyl ethenylidenebisphosphonate 49
LIPOPHILIC NO-DONOR AND LIPOPHILIC ANTIOXIDANT COMPOUND IN MYOCARDIAL PROTECTION AGAINST ISCHEMIA-REPERFUSION INJURY 49
The Furoxan System: Design of Selective Nitric Oxide (NO) Donor Inhibitors of COX-2 Endowed with Anti-Aggregatory and Vasodilating Activities 47
Nitric oxide (NO) donor beta(2)-agonists:furoxan derivatives containing the fenoterol moiety and related furazans 46
High-speed gas-chromatography in doping control analyses: fast GC, ultrafast GC and fast GC/MS determination of Doping Substances 45
Fast gas-chromatography coupled mass spectrometry: rapid determination of diuretics in doping analysis 45
Nicorandil analogues containing NO-donor furoxans and related furazans 43
Simultaneous ultrasound-assisted water extraction and β-cyclodextrin encapsulation of polyphenols from Mangifera indica stem bark in counteracting TNFα-induced endothelial dysfunction 37
Potential Histamine H2-receptor Antagonists: Synthesis and Pharmacological Activity of Derivatives Containing Acylaminofurazan moieties 35
Totale 10.442
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.802
article - articoli 0
book - libri 0
conference - conferenze 7.703
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.505
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021894 99 59 74 48 62 56 55 37 156 62 47 139
2021/20221.307 40 40 63 85 98 16 142 83 43 164 267 266
2022/20231.675 207 167 60 168 135 389 211 98 125 31 50 34
2023/2024631 76 90 47 32 60 106 20 37 4 27 38 94
2024/20251.821 13 119 91 184 398 93 43 98 260 131 133 258
2025/2026131 131 0 0 0 0 0 0 0 0 0 0 0
Totale 10.442